Sterzyńska, K., Kaźmierczak, D., Klejewski, A., Świerczewska, M., Wojtowicz, K., Nowacka, M., . . . Januchowski, R. (2019). Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated with Drug Resistance in Ovarian Cancer Cell Lines. Int J Mol Sci.
Style de citation ChicagoSterzyńska, Karolina, Dominika Kaźmierczak, Andrzej Klejewski, Monika Świerczewska, Karolina Wojtowicz, Marta Nowacka, Jacek Brązert, Michał Nowicki, et Radosław Januchowski. "Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated With Drug Resistance in Ovarian Cancer Cell Lines." Int J Mol Sci 2019.
Style de citation MLASterzyńska, Karolina, et al. "Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated With Drug Resistance in Ovarian Cancer Cell Lines." Int J Mol Sci 2019.